← All trials
NCT05008549
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 26, 2021
- Primary completion
- Nov 30, 2022
- Completion date
- Nov 30, 2022
- First posted
- Aug 17, 2021
- Last posted
- Aug 17, 2021
- Enrollment
- 25
- Arms / groups
- 6 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Ocean Spray, Inc.Lead sponsor
- Atlantia Food Clinical TrialsCollaborator
- Atlantia Food Clinical TrialsOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.